自身免疫性疾病的精准医学:事实还是虚构
该综述讨论精准医学在自身免疫性疾病中的实际意义与潜力,指出尽管分子通路研究提供了重要见解,但转录组等分子数据极少用于疾病分层、预测或诊断。仅I型干扰素特征被考虑用于治疗目的,尤其在系统性红斑狼疮(SLE)中。作者主张应从已确立疾病的精准医学转向预测疾病发生的预防医学。
要点
- 分子研究多揭示通路,但极少用于疾病分层、预测或诊断。
- 仅I型干扰素特征被考虑用于治疗,尤其在SLE中。
- 应推动从已病精准医学转向预测发病的预防医学。
核心结论
- 精准医学在自身免疫病中的实际应用有限,仅I型干扰素特征被考虑用于治疗目的,尤其在SLE中。
研究设计与样本
- 本文为综述,聚焦于自身免疫性疾病精准医学的转化应用及单细胞分子研究的贡献。
主要发现
- 多项研究提供了分子通路的重要见解,但转录组等分子数据极少用于疾病分层、预测或诊断。
临床怎么用
- 临床应关注从已确立疾病的精准医学向预测疾病发生的预防医学转变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Much is said about precision medicine, but its real significance and potential are far from certain. Several studies in each of the autoimmune diseases have provided important insights into molecular pathways, but the use of molecular studies, particularly those looking into transcriptome pathways, has seldom approached the possibility of using the data for disease stratification and then for prediction, or for diagnosis. Only the type I IFN signature has been considered for therapeutic purposes, particularly in the case of SLE. This review provides an update on precision medicine, on what can be translated into clinical practice and on what single-cell molecular studies contribute to our knowledge of autoimmune diseases, focusing on a few examples. The main message is that we should try to move from precision medicine of established diseases to preventive medicine in order to predict the development of disease.
引用
- Toro-Domínguez D, Alarcón-Riquelme ME. Precision medicine in autoimmune diseases: fact or fiction. Rheumatology (Oxford). 2021. PMID: 34003926. doi:10.1093/rheumatology/keab448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。